248 related articles for article (PubMed ID: 32931661)
1. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database.
Li X; Guo K; Feng Y; Guo Y
Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661
[TBL] [Abstract][Full Text] [Related]
2. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.
Zhu X; Zhou J; Zhou L; Zhang M; Gao C; Tao L
J Transl Med; 2022 Sep; 20(1):405. PubMed ID: 36064552
[TBL] [Abstract][Full Text] [Related]
3. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
4. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
5. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
7. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
[TBL] [Abstract][Full Text] [Related]
8. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for primary cancer can reduce the risk of head and neck second primary malignancy: a propensity-matched analysis.
Xiong L; Yu H; Wei W; Wang C; Li B; Liu H; Cheng A; Li D; Han Z; Feng Z
Clin Oral Investig; 2023 Feb; 27(2):571-580. PubMed ID: 36239788
[TBL] [Abstract][Full Text] [Related]
10. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
11. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
12. Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.
Wang SW; Chan LP; Wang LF; Wu CW; Lin SH; Huang TY; Lee KW
PLoS One; 2022; 17(2):e0263773. PubMed ID: 35167611
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival.
Ding L; Bi ZF; Yuan H; Zhao XH; Guan XD; Yao HR; Liu YM
Laryngoscope; 2021 Feb; 131(2):E489-E499. PubMed ID: 33135805
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study.
Liu Y; Zhang P; Zhang Y; Zheng L; Xu W; Hou D; Kang Z
Sci Rep; 2021 Jan; 11(1):1293. PubMed ID: 33446816
[TBL] [Abstract][Full Text] [Related]
15. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study.
Xiao Y; Peng S; Hu Y; Zhang J; Cao X
Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Tan X; Yang H; Chen J; Liu G
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744320
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
19. A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodes.
Ali AN; Switchenko JM; Kim S; Kowalski J; El-Deiry MW; Beitler JJ
Cancer; 2014 Nov; 120(22):3469-76. PubMed ID: 25060659
[TBL] [Abstract][Full Text] [Related]
20. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
